CytomX Therapeutics CTMX
NASDAQ CTMX
$2.49 -0.02 (-0.60%)
As of: Oct 21, 2026 · 10:09 AM EDT

CytomX Therapeutics (CTMX) Debt Ratio (2014 - 2015)

Updated

CytomX Therapeutics' (CTMX) Debt Ratio was 0.04 for Q4 2014.

Analysis

CytomX Therapeutics (CTMX) Debt Ratio (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,129.39 Bn 1,097.98 Bn 19.71 Bn 0.39
2 Johnson & Johnson 615.68 Bn 534.21 Bn 17.26 Bn 0.24
3 AbbVie 505.77 Bn 478.89 Bn 12.70 Bn 0.52
4 Merck 366.50 Bn 320.88 Bn 12.21 Bn 0.42
5 Novartis Ag 297.33 Bn 261.32 Bn 11.24 Bn 0.08
6 Astrazeneca 261.02 Bn 234.71 Bn 12.86 Bn 0.28
7 Amgen 235.47 Bn 190.87 Bn 7.24 Bn 0.60
8 Gilead Sciences 189.20 Bn 163.40 Bn 6.22 Bn 0.53
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn 0.31
10 CytomX Therapeutics 547.35 Mn -410.32 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 0.00
Dec 31, 2014 0.04
API Access

CytomX Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CTMX&period=max&api_key=YOUR_API_KEY